NDAINJECTIONINJECTABLEPriority Review
Approved
Jun 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 19h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Orinase Diagnostic is a tolbutamide sodium injectable formulation used historically as a diagnostic agent to assess pancreatic beta cell function and insulin secretion capacity. It is a first-generation sulfonylurea compound administered intravenously to stimulate insulin release in response to glucose challenge. This product represents a diagnostic rather than therapeutic use case, positioning it distinctly within the endocrinology diagnostic space.
LOE Approaching
Product approaching loss of exclusivity with minimal commercial activity signals, indicating small team sizes and limited career growth trajectory in commercial roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Orinase Diagnostic offers limited career advancement opportunities given its LOE-approaching status and minimal commercial activity. Roles focus on compliance, regulatory maintenance, and operational efficiency rather than growth, making it suitable for specialists seeking stable, non-sales positions in legacy product management.
Product Manager (Legacy)Regulatory Affairs Specialist
Worked on ORINASE DIAGNOSTIC at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.